LRR Energy LP (NYSE:LRE): Oppenheimer sees LRR Energy LP’s valuation as inviting ahead of expected acquisitions and balance sheet strengthening efforts. Shares are Outperform rated with a $24 price target.
Medicis Pharmaceutical Corp. (NYSE:MRX): Morgan Stanley said that the complaint filed by Q-Med should not stop Medicis Pharmaceutical Corp. from closing the deal.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Lazard Ltd. (NYSE:LAZ): Argus believes that Lazard Ltd. has continued to gain M&A market share and they think that company can meet their margin targets. The firm reiterates a Buy rating on their stock.
MAP Pharmaceuticals, Inc. (NASDAQ:MAPP): Cancaccord defended MAP Pharmaceuticals, Inc.’s shares.
J. C. Penney Company, Inc. (NYSE:JCP): Macquarie defended J.C. Penney Company, Inc.’s shares.